Stock Earnings Investing in Galectin Therapeutics Inc (GALT) Is Getting More Attractive Galectin Therapeutics Inc’s recently made public that its Director ELDRED KARY acquired Company’s shares for reported $2925.0 on Jul 21
Analysts Viewpoint Investing in Galectin Therapeutics Inc (GALT): What You Must Know Galectin Therapeutics Inc’s recently made public that its Director Shlevin Harold H. acquired Company’s shares for reported $7540.0 on Dec
Insiders Updates Taking a Closer Look At Galectin Therapeutics Inc (GALT) Following Its Recent Trade Galectin Therapeutics Inc’s filing revealed that its Director Shlevin Harold H. acquired Company’s shares for reported $7540.0 on Dec 30